These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 6376034)

  • 1. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM.
    Karam JH; Sanz N; Salamon E; Nolte MS
    Diabetes; 1986 Dec; 35(12):1314-20. PubMed ID: 3533680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
    Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
    Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.
    DeFronzo RA; Simonson DC
    Diabetes Care; 1984; 7 Suppl 1():72-80. PubMed ID: 6428844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus.
    Campbell PJ; Mandarino LJ; Gerich JE
    Metabolism; 1988 Jan; 37(1):15-21. PubMed ID: 3275857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
    Groop L; Luzi L; Melander A; Groop PH; Ratheiser K; Simonson DC; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1320-8. PubMed ID: 3117609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent diabetes mellitus. Results of randomized crossover trial.
    Firth R; Bell P; Marsh M; Rizza RA
    Diabetes; 1987 Oct; 36(10):1130-8. PubMed ID: 3308584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.
    Kolterman OG; Olefsky JM
    Diabetes Care; 1984; 7 Suppl 1():81-8. PubMed ID: 6376033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.
    Schuster DP; Osei K; Zipf WB
    Metabolism; 1996 Dec; 45(12):1514-20. PubMed ID: 8969285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics.
    Pisu E; Lombardi A; De Benedictis D; Bozzo C; Chiara E; Baggiore C; Bruno A; Cravero L; Pagano G; Lenti G
    Acta Diabetol Lat; 1986; 23(3):215-25. PubMed ID: 3538736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of oral sulfonylurea agents on hepatic glucose uptake.
    Kawamori R; Morishima T; Kubota M; Matsuhisa M; Ikeda M; Kamada T
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S109-13. PubMed ID: 8529503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.
    Rizza RA; Mandarino LJ; Gerich JE
    J Clin Endocrinol Metab; 1982 Jan; 54(1):131-8. PubMed ID: 7033265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of methyltestosterone on insulin secretion and sensitivity in women.
    Diamond MP; Grainger D; Diamond MC; Sherwin RS; Defronzo RA
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4420-5. PubMed ID: 9851788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.
    Pagano G; Cavallo-Perin P; Cassader M; Bruno A; Ozzello A; Masciola P; Dall'omo AM; Imbimbo B
    J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
    Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
    J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
    Mari A
    Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-sensitive and insulin-resistant variants in NIDDM.
    Banerji MA; Lebovitz HE
    Diabetes; 1989 Jun; 38(6):784-92. PubMed ID: 2656347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal coupling of insulin receptor binding in noninsulin-dependent diabetes.
    Mandarino LJ; Campbell PJ; Gottesman IS; Gerich JE
    Am J Physiol; 1984 Nov; 247(5 Pt 1):E688-92. PubMed ID: 6388357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
    Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
    Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.